AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Essential Maintenance
: All Authorea-powered sites will be offline 9am-10am EDT Tuesday 28 May
and 11pm-1am EDT Tuesday 28-Wednesday 29 May. We apologise for any inconvenience.
Farah Rahat
Public Documents
1
Case Report: Successful Rechallenge With Cisplatin Following Cisplatin Induced Ischem...
Farah Rahat
and 4 more
May 16, 2022
Cisplatin is a widely used platinum-based chemotherapy agent. Its common adverse effects are neuropathy, nephrotoxicity, electrolyte abnormality, and rarely causing thrombotic vascular toxicity. We present a patient known to have Small-cell Lung Cancer who developed ischemic cerebrovascular accident (CVA) after receiving chemotherapy regimen including cisplatin.